Individualized Home-based Exercise Program for Patient With Systemic Sclerosis.

Key facts

Sponsor

Universita di Verona

Principal Investigator

Marcello Ferrari, Professor

Universita di Verona

Intervention

Home-care rehabilitation group (HCRG)(behavioral)

Enrollment

33 enrolled

Eligibility

18-85 years · All sexes

Timeline

2017 – 2018

Study locations (1)

• Azienda Ospedaliera, SSO respiratory pathophysiology Unit, Verona, Verona, Italy/Verona, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1, PHASE2NCT07473154
  Controlling Hyperactive Immunity With Long-lived Lymphocytes
  Quell Therapeutics Limited
• RECRUITINGPHASE1, PHASE2NCT06947473
  Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
  Beijing GoBroad Hospital
• RECRUITINGPHASE2NCT05029336
  Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
  Stephan Grupp MD PhD
• RECRUITINGPHASE2NCT07047690
  A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
  Galderma R&D
• RECRUITINGPHASE2NCT07287670
  EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
  Mediar Therapeutics
• RECRUITINGNCT07256418
  Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma
  Centre Hospitalier Universitaire Dijon
• RECRUITINGPHASE1NCT07295847
  A Study of AZD0120 in Autoimmune Diseases
  AstraZeneca
• RECRUITINGNANCT07292961
  Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma
  Hacettepe University

See all trials for Diffuse cutaneous systemic sclerosis →